SCHEMBL22891670

SCHEMBL22891670

c1ccc(Nc2ccc3c(c2)N(c2ccc4ccccc4c2)c2ccccc2C32c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ PDK2 Q15119 1/20 0.38
▸ GNG2 P59768 1/20 0.35
▸ GNB1 P62873 1/20 0.35
▸ HSP90AA1 P07900 2/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALOX12 P18054 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ SNCA P37840 1/20 0.33
▸ CYP26A1 O43174 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22891639 0.93 ALDH1A1 (0.46) ALDH1A1HPGDHSD17B10CYP3A4PDK2
SCHEMBL22891764 0.88 GNG2 (0.45) ALDH1A1HPGDHSD17B10CYP3A4PDK2
SCHEMBL22891640 0.86 PDK2 (0.40) ALDH1A1HPGDHSD17B10CYP3A4PDK2
SCHEMBL22891526 0.85 PDK2 (0.38) PDK2GNG2GNB1HSP90AA1MEN1
SCHEMBL22891669 0.84 PDK2 (0.38) ALDH1A1HPGDHSD17B10CYP3A4PDK2
SCHEMBL22891468 0.83 PDK2 (0.43) ALDH1A1HPGDHSD17B10CYP3A4PDK2
SCHEMBL22891638 0.81 PDK2 (0.40) ALDH1A1HPGDHSD17B10CYP3A4PDK2
SCHEMBL24027640 0.81 CYP2A6 (0.40) ALDH1A1HPGDPDK2HSP90AA1MEN1
SCHEMBL22891467 0.80 PDK2 (0.49) ALDH1A1HPGDHSD17B10CYP3A4PDK2
SCHEMBL22891464 0.80 PDK2 (0.46) ALDH1A1HPGDHSD17B10CYP3A4PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3764416-B1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO LTD (KR) 2022-01-26 — — EP disclosed
US-20210013420-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-01-14 — — US disclosed
EP-3764416-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF Duk San Neolux Co., Ltd. (KR) 2021-01-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210013420-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, OR10J3 ALDH1A1 1135/4885HPGD 3149/4885HSD17B10 2763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback